Mumbai, Nov. 25 -- Glenmark Pharmaceuticals announced the launch of Nebzmart(R) GFB Smartules(R) and Glenmark Airz(R) FB Smartules(R), the world's first nebulized, fixed-dose triple therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD).

Published by HT Digital Content Services with permission from Capital Market....